Skip to main content

Table 2 Studies reporting AGWs in men

From: Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis

Author, year Country Study design Study population Sample Mean or Median age Prevalence of AGWs2(%) Prevalence of HIV-1% Comments
size (years, range/IQR1)
East Africa
Grijsen et al., 2008 [24] Kenya §Baseline of a prospective cohort study Men at high-risk for HIV infection 536 27 (24–33) 9/500 (1.8) 21.0  
Smith et al., 2010 [45] Kenya §Baseline of RCT3 on male circumcision HIV negative sexually active men 2168 20 (19–28) 12/2168 (0.6) Overall 10/1089 (0.9) HIV + 2/1079 ( 0.2) HIV-   
Tobian et al., 2012 [46] Uganda Cross-sectional Heterosexual men 1399 15-49 23/1399 (1.6)a Overall 16/421 (3.8)a HIV + 7/978 (0.7)a HIV –   
Central and South Africa
Le Bacq et al., 1993 [31] Zimbabwe §Cross-sectional New STD clinic attendees 319   39/319 (12.2) 61.0  
Maher et al. 1995 [32] Malawi §Cross-sectional In-patient male patients in general medical care 62 39 (20–90) 3/62 (4.8)   
Machekano et al., 2000 [47] Zimbabwe §Baseline of prospective cohort study Male factory workers who reported symptoms of STDs 374   22/374 (6.0) 20  
Müller et al., 2010 [48] South Africa §Cross-sectional Heterosexual men attending sexual health services 214 29.8 ± 7.5 108/214 (50.5) 49.5  
West Africa
Okesola et al., 2000 [40] Nigeria §Cross-sectional STD2 clinic attendees 1,373 17-74 4.1   
Wade et al., 2005 [49] Senegal §Cross sectional Men who have sex with men 463 18-52 13/463 (2.8) 18.1 21.5% Overall 0.5% HIV-2 2 2.9% HIV-1 & HIV-
  1. a Self-reported prevalence.
  2. 1Inter Quartile Range.
  3. 2Commercial sexual workers.
  4. 3Randomized Controlled Trial.
  5. §hospital-based study.
  6. Population-based study.